Vironexis Biotherapeutics

Biotechnology Research • United States • 11-20 Employees

Company overview

Headquarters	United States
Website	vironexis.com
NAICS	541714
Founded	2021
Employees	11-20
Socials

Key Contacts at Vironexis Biotherapeutics

Timothy Cripe

Co-Founder

Debashree Das

Associate Director

Tookie May

Associate Director, Clinical Operations

Tracy Lou

Director, Clinical Operations

Vironexis Biotherapeutics Email Formats

Vironexis Biotherapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@vironexis.com), used 64.3% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@vironexis.com	64.3%
{first initial}.{last name}	j.doe@vironexis.com	35.7%

About Vironexis Biotherapeutics

Vironexis is focused on transforming the future of cancer treatment by pioneering AAV-delivered T-cell immunotherapy. Our TransJoin™ AAV Gene Therapy Platform enables the creation of off-the-shelf, single-dose gene therapies designed to overcome the key challenges and shortcomings of current immunotherapies, including CAR-T. Our current pipeline includes more than ten product candidates for blood-based cancers, solid tumor metastasis prevention, and a cancer vaccine. Our lead program, VNX-101, for the treatment of CD19+ acute lymphoblastic leukemia, is anticipated to begin clinical trials in the fourth quarter of 2024.

Vironexis Biotherapeutics revenue & valuation

Annual revenue	$1,026,660
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,300,000
Total funding	$26,000,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Director

C-Suite

Employees by Department

Vironexis Biotherapeutics has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Vironexis Biotherapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-10-12	3	$26,000,000

Funding Insights

$26,000,000

Total funding amount

$26,000,000

Most recent funding amount

Number of funding rounds

Vironexis Biotherapeutics Tech Stack

Discover the technologies and tools that power Vironexis Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Amazon Web Services

PaaS

PHP

Programming languages

Open Graph

Miscellaneous

GSAP

JavaScript frameworks

WordPress

Blogs

core-js

JavaScript libraries

Ubuntu

Operating systems

Google Analytics

Analytics

MySQL

Databases

CookieYes

Cookie compliance

Priority Hints

Performance

Frequently asked questions

Vironexis Biotherapeutics is located in US.

Vironexis Biotherapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Vironexis Biotherapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Vironexis Biotherapeutics has raised a total of $26,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.